A carregar...
Learning experiences with sunitinib continuous daily dosing in patients with pancreatic neuroendocrine tumours
Molecular strategies to improve outcomes for patients with pancreatic neuroendocrine tumours (nets) have focused on targeting vascular endothelial growth factor, platelet-derived growth factor, and mtor (the mammalian target of rapamycin). This approach has led to the regulatory approval of two mole...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4257114/ https://ncbi.nlm.nih.gov/pubmed/25489258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.1647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|